Australia markets open in 2 hours 37 minutes

TFF Pharmaceuticals, Inc. (TFFP)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
5.36+0.37 (+7.41%)
At close: 04:00PM EDT
5.10 -0.26 (-4.85%)
After hours: 04:30PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close4.99
Open5.16
Bid4.75 x 1000
Ask5.37 x 1000
Day's range5.07 - 5.43
52-week range3.60 - 12.28
Volume193,571
Avg. volume133,514
Market cap136.004M
Beta (5Y monthly)2.14
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    TFF Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update

    Announced Collaboration with Catalent to Further Expand Thin Film Freezing Applications with a Focus on Biologic Drug Development Announced Second CRADA Agreement with USAMRIID and Geneva Foundation to Develop Novel Therapies Using Thin Film Freezing to Combat SARS-CoV-2, Ebola, and Marburg Viruses Initiated Phase 2 Trials of Inhaled Voriconazole Powder and Inhaled Tacrolimus Powder With Interim Data for Each Program Expected Later in 2022 Significant Progress Made in Inhaled Niclosamide Powder

  • GlobeNewswire

    TFF Pharmaceuticals Announces Multiple Presentations Highlighting Broad Applicability of its Thin Film Freezing Technology at Respiratory Drug Delivery Meeting (RDD)

    Thin Film Freezing Technology Co-Inventor Dr. Robert O. Williams III to Deliver Platform Presentation of Data on Stabilizing and Delivering Antivirals, Antibodies and Vaccines using Thin Film Freezing Technology in the Fight Against COVID-19 Members of Dr. Williams’ Lab at The University of Texas at Austin will Present Five Posters at RDD Meeting Research Showcases Versatility and Differentiation of the Thin Film Freezing Technology Platform and its Potential to Address Multiple Challenges in Dr

  • GlobeNewswire

    TFF Pharmaceuticals to Hold First Quarter 2022 Financial and Business Results Conference Call on May 11, 2022

    Company conference call and webcast at 4:30 PM ETFORT WORTH, Texas, April 29, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that it will release its financial results and business update for the first quarter of 2022 on Wednesday, May 11, 2022, after the close of the U.S. financial ma